Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07469189) titled 'A Study on Hydroxocobalamin Given to Healthy Individual to Monitor Symptoms' on March 10.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Brigham and Women's Hospital
Condition:
Hydroxocobalamin Adverse Reaction
Intervention:
Drug: Hydroxocobalamin
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: January 2, 2023
Target Sample Size: 10
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07469189
Published by ...